These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25569091)

  • 1. Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
    Mezei ZA; Bereczky Z; Katona É; Gindele R; Balogh E; Fiatal S; Balogh L; Czuriga I; Ádány R; Édes I; Muszbek L
    Int J Mol Sci; 2015 Jan; 16(1):1143-59. PubMed ID: 25569091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
    Mezei ZA; Katona É; Kállai J; Bereczky Z; Molnár É; Kovács B; Ajzner É; Bagoly Z; Miklós T; Muszbek L
    Thromb Res; 2016 Dec; 148():101-106. PubMed ID: 27821352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
    Balogh L; Katona É; Mezei ZA; Kállai J; Gindele R; Édes I; Muszbek L; Papp Z; Bereczky Z
    Mol Cell Biochem; 2018 Nov; 448(1-2):199-209. PubMed ID: 29484525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.
    Guodong Jin ; Beili Feng ; Peng Chen ; Oushan Tang ; Jian Wang ; Ji Ma ; Yuping Shi ; Geng Xu
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):208-13. PubMed ID: 20211923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.
    Gemmati D; Federici F; Campo G; Tognazzo S; Serino ML; De Mattei M; Valgimigli M; Malagutti P; Guardigli G; Ferraresi P; Bernardi F; Ferrari R; Scapoli GL; Catozzi L
    Mol Med; 2007; 13(1-2):112-20. PubMed ID: 17515963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Mezei ZA; Katona É; Kállai J; Bereczky Z; Somodi L; Molnár É; Kovács B; Miklós T; Ajzner É; Muszbek L
    Thromb Res; 2017 Oct; 158():93-97. PubMed ID: 28865246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.
    Wartiovaara U; Perola M; Mikkola H; Tötterman K; Savolainen V; Penttilä A; Grant PJ; Tikkanen MJ; Vartiainen E; Karhunen PJ; Peltonen L; Palotie A
    Atherosclerosis; 1999 Feb; 142(2):295-300. PubMed ID: 10030380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
    Reiner AP; Heckbert SR; Vos HL; Ariëns RA; Lemaitre RN; Smith NL; Lumley T; Rea TD; Hindorff LA; Schellenbaum GD; Rosendaal FR; Siscovick DS; Psaty BM
    Blood; 2003 Jul; 102(1):25-30. PubMed ID: 12456499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
    Warner D; Mansfield MW; Grant PJ
    Thromb Haemost; 2001 Mar; 85(3):408-11. PubMed ID: 11307805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.
    Kohler HP; Futers TS; Grant PJ
    Thromb Haemost; 1999 Apr; 81(4):511-5. PubMed ID: 10235430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.